PolyU-Peking U joint research breaks new ground in synthesis of anti-cancer agents

An anti-cancer research jointly conducted by The Hong Kong Polytechnic University (PolyU) and Peking University Shenzhen Graduate School (PKUSZ) has led to the first total synthesis of an anti-cancer marine natural product, grassypeptolide.

Dr Ye Tao

An anti-cancer research jointly conducted by The Hong Kong Polytechnic University (PolyU) and Peking University Shenzhen Graduate School (PKUSZ) has led to the first total synthesis of an anti-cancer marine natural product, grassypeptolide. Not only was this important finding featured on the inside front cover of the authoritative journal Chemical Communications [Issue 40, Volume 46, (2010)], but also highlighted by Nature China.

This cutting-edge research has combined the effort of two research teams from PolyU and PKUSZ, both working under the leadership of Principal Investigator Dr Tao YE (葉濤), Associate Professor of PolyU’s Department of Applied Biology and Chemical Technology. This breakthrough has paved the way for further development of anti-cancer drugs from this natural product grassypeptolide — a compound isolated from a marine bacteria — which has recently emerged as a promising anti-cancer agent.

Despite its fascinating features, grassypeptolide was barely available from natural sources. But now it can be constructed by total chemical synthesis in 17 steps with this breakthrough. The key challenges in the total synthesis of grassypeptolide are the forming of the 31-member ring of grassypeptolide and the introducing of the two smaller thiazoline heterocycles — five-member rings containing sulphur and nitrogen — into the 31-member ring. The researchers constructed the 31-membered macrocycle via a precursor with more favorable cyclization kinetics; and introduced the thiazoline heterocycles at a later stage of the synthesis to prevent the thiazoline heterocycles from undergoing side reactions.

According to Dr Ye, chemical synthesis of natural products and their analogues has been a key tool for drug discovery and development. In cases where the lead compound is obtainable only in minute quantities, thus not enough to carry out further bioassay tests, chemical synthesis can solve the supply problem. Furthermore, the synthesis presents opportunities for modifying the structure of lead compound, with the ultimate aim of improving activity or the physicochemical/biological properties of the lead molecule. Synthesis is also crucial in the development of structure-activity relationships as the ability to make analogues of the lead compound chemically is a prerequisite for such studies.

A leading synthetic chemist in the field of chemical biology, Dr Tao YE has received large amounts of funding from the Research Grants Council, for example, in both the Biology and Medicine Discipline (HK$1,739,184 in 2007) and the Physical Sciences Discipline (HK$1,259,250 in 2010). In 2010 alone, his research activities already resulted in the publication of eight original research papers in top research journals with an impact factor greater than five.

The write-up on this breakthrough in Nature China can be viewed at URL: (http://www.nature.com/nchina/2010/101103/full/
nchina.2010.121.html)

*****
Press contact:Miss Hazel Kwong
Department of Applied Biology & Chemical Technology

Tel: (852) 3400 8761
Email: [email protected]

Press contact:Miss Reni Lam
Department of Applied Biology & Chemical Technology

Tel: (852) 3400 8761 or 3400 8722
Email: [email protected]

Published: 17 Nov 2010

Contact details:

General Information (Communications and Public Affairs Office)

Hung Hom Kowloon

(852) 2766 5111
Country: 
News topics: 
Content type: 
Reference: 

Medicine